Pancreatic Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
Cancer Arm (for people with pancreatic cancer):
- People between 40 and 75 years old
- People who have been diagnosed with pancreatic cancer through clinical assessment and/or laboratory/tissue testing
- People who have not received, and are not currently receiving, any cancer treatments — including surgery, radiation, chemotherapy, hormone therapy, targeted therapy, immunotherapy, or similar treatments
- People who are able to give written consent and are willing to follow all study procedures
Benign Disease Arm (for people with non-cancerous pancreatic conditions):
- People between 40 and 75 years old
- People who have been diagnosed with a non-cancerous pancreatic condition, such as pancreatic intraepithelial neoplasia, pancreatic cysts, or chronic pancreatitis
- People who have not received, and are not currently receiving, any cancer treatments — including surgery, radiation, chemotherapy, hormone therapy, targeted therapy, immunotherapy, or similar treatments
- People who are able to give written consent and are willing to follow all study procedures
Who may not be able to join:
- People who are pregnant or currently breastfeeding
- People who have been diagnosed with any other type of cancer, either in the past or currently
- People who have had a severe infection (such as severe COVID-19 or sepsis) or a fever of 38.0°C or higher in the 14 days before the blood sample is taken
- People who have received an organ transplant, bone marrow transplant, or stem cell transplant at any point
- People who have received a blood transfusion within the 30 days before the blood sample is taken
- People who have taken certain medications in the 14 days before the blood sample is taken — including oral or intravenous antibiotics, steroids (glucocorticoids), or specific other drugs such as azacitidine, decitabine, procainamide, hydrazine, or arsenic trioxide
- People whom the trial investigators determine are not suitable for other reasons (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Xian-Jun Yu, M.D., Ph.D., Fudan University
Phone: +86 21 64175590
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Performance of cfDNA methylation-based model for discriminating pancreatic cancer versus non-cancer
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.